Drug – bio-affecting and body treating compositions – Effervescent or pressurized fluid containing – Organic pressurized fluid
Reexamination Certificate
2007-07-17
2007-07-17
Richter, Johann (Department: 1616)
Drug, bio-affecting and body treating compositions
Effervescent or pressurized fluid containing
Organic pressurized fluid
C514S291000, C514S304000, C514S826000
Reexamination Certificate
active
10400127
ABSTRACT:
The invention relates to propellant gas formulations containing suspensions of the crystalline anhydrate of (1α,2β,4β,5α,7β)-7-[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane-bromide.
REFERENCES:
patent: 4042700 (1977-08-01), Banholzer et al.
patent: 4608377 (1986-08-01), Banholzer et al.
patent: 4783534 (1988-11-01), Banholzer
patent: 5610163 (1997-03-01), Banholzer et al.
patent: 5654314 (1997-08-01), Banholzer et al.
patent: 5770738 (1998-06-01), Banholzer et al.
patent: 5952505 (1999-09-01), Banholzer
patent: 6433027 (2002-08-01), Bozung et al.
patent: 6455524 (2002-09-01), Bozung et al.
patent: 6475467 (2002-11-01), Keller et al.
patent: 6486321 (2002-11-01), Banholzer et al.
patent: 6506900 (2003-01-01), Banholzer et al.
patent: 6585959 (2003-07-01), Walz et al.
patent: 6608054 (2003-08-01), Meade et al.
patent: 6608055 (2003-08-01), Werthmann
patent: 6620438 (2003-09-01), Pairet et al.
patent: 6696042 (2004-02-01), Pairet et al.
patent: 6777423 (2004-08-01), Banholzer et al.
patent: 6881422 (2005-04-01), Banholzer et al.
patent: 6890517 (2005-05-01), Barth et al.
patent: 6908928 (2005-06-01), Banholzer et al.
patent: 2002/0110529 (2002-08-01), Bechtold-Peters et al.
patent: 2002/0122773 (2002-09-01), Pairet et al.
patent: 2002/0137764 (2002-09-01), Crechsel et al.
patent: 2002/0151541 (2002-10-01), Pairet et al.
patent: 2002/0169181 (2002-11-01), Pairet et al.
patent: 2002/0169321 (2002-11-01), Banholzer et al.
patent: 2002/0183347 (2002-12-01), Meade et al.
patent: 2002/0193392 (2002-12-01), Schmelzer et al.
patent: 2002/0193393 (2002-12-01), Pairet et al.
patent: 2003/0070679 (2003-04-01), Bechtold-Peters et al.
patent: 2003/0113269 (2003-06-01), Gavin
patent: 2003/0119802 (2003-06-01), Gavin
patent: 2003/0119859 (2003-06-01), Gavin
patent: 2003/0125350 (2003-07-01), Hassan et al.
patent: 2003/0139383 (2003-07-01), Gavin et al.
patent: 2003/0235538 (2003-12-01), Zierenberg
patent: 2004/0002510 (2004-01-01), Bender et al.
patent: 2004/0018153 (2004-01-01), Schmelzer
patent: 2004/0019073 (2004-01-01), Barth et al.
patent: 2004/0087793 (2004-05-01), Banholzer et al.
patent: 2004/0132761 (2004-07-01), Barth et al.
patent: 2004/0136919 (2004-07-01), Hartig et al.
patent: 2004/0228806 (2004-11-01), Bechtold-Peters et al.
patent: 2005/0009857 (2005-01-01), Banholzer et al.
patent: 2005/0058606 (2005-03-01), Six et al.
patent: 2005/0084457 (2005-04-01), Bechtold-Peters et al.
patent: 2005/0143410 (2005-06-01), Pfrengle et al.
patent: 2005/0147564 (2005-07-01), Barth et al.
patent: 2779347 (1999-12-01), None
patent: 9011744 (1990-09-01), None
patent: 0 418 716 (1991-03-01), None
patent: WO 92/18110 (1992-10-01), None
patent: WO 94/13262 (1994-06-01), None
patent: WO 95/05805 (1995-03-01), None
patent: WO 00/07567 (2000-02-01), None
patent: WO 01/78736 (2001-10-01), None
patent: WO 01/78739 (2001-10-01), None
patent: WO 01/78741 (2001-10-01), None
patent: WO 01/78743 (2001-10-01), None
patent: WO 02/30928 (2002-04-01), None
patent: WO 02/36106 (2002-05-01), None
patent: WO 02/36106 (2002-05-01), None
patent: WO 02/36163 (2002-05-01), None
patent: WO 02/38154 (2002-05-01), None
patent: WO 02/051840 (2002-07-01), None
patent: WO 02/069944 (2002-09-01), None
patent: WO 02/075034 (2002-09-01), None
U.S. Appl. No. 07/987,852, filed Dec. 9, 1992, Jager et al.
Accession No. (AN) : 1998:8089, USAN, Generic Name (CN) : Tiotropium Bromide, CAS Registry No. (RN) ; 139404-48-1, Printout (“the USAN reference”) (1998).
P.J. Barnes, et al. “Tiotropium Bromide (Ba 679 BR), A Novel Long-Acting Muscarinic Antagonist for the Treatment of Obstructive Airways Disease” Life Sciences, vol. 56, No. 11/12, pp. 853-859, 1995.
Boehringer Ingelheim Pharma GmbH & Co. KG
Devlin Mary-Ellen M.
Haghighatian Mina
Morris Michael P.
Petka Wendy
LandOfFree
HFA suspension formulations of an anhydrate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HFA suspension formulations of an anhydrate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HFA suspension formulations of an anhydrate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3782698